ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,827.20
      0.94%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,232.05
      -0.73%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Avalon Pharmaceuticals (MM) (AVRX)

      7. Avalon Pharmaceuticals (MM) (AVRX) News

      AVRX

      Avalon (AVRX)

      Avalon Pharmaceuticals (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVRX
      DateTimeSourceHeadlineSymbolCompany
      04/29/20089:54AMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/14/200811:00AMBusiness WireAvalon Pharmaceuticals Identifies Small Molecule Inhibitors of the Aurora/Centrosome Cancer Pathway that Block PLK3 Protein FuncNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/04/20082:00PMBusiness WireAvalon Pharmaceuticals Receives Audit Opinion Containing Going Concern StatementNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/02/20085:16PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/31/20082:34PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/19/20084:25PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/19/20084:15PMBusiness WireAvalon Pharmaceuticals Reports Fourth Quarter and Full Year 2007 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/17/20083:59PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/17/20083:57PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/17/20083:55PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/17/20088:00AMBusiness WireAvalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of DirectorsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/12/20084:58PMBusiness WireAvalon Pharmaceuticals to Release Fourth Quarter and Full Year 2007 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/11/20081:17PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/15/20084:10PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/14/20084:32PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/14/20088:00AMBusiness WireAvalon Pharmaceuticals to Present at 20th Annual Roth Capital Partners Growth Stock ConferenceNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/13/20084:38PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/13/20083:48PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/13/20083:30PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/12/20083:46PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/08/20084:41PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/06/200812:35PMBusiness WireAvalon Pharmaceuticals to Present at BIO CEO & Investor ConferenceNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      01/28/200812:00PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      01/25/20081:25PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      01/14/20088:00AMBusiness WireAvalon Pharmaceuticals Announces the Initiation of Compound Characterization Phase in Drug Discovery CollaborationNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      12/10/20078:00AMBusiness WireAvalon Pharmaceuticals Announces their Beta-catenin Inhibitors Demonstrate Potent Cytotoxic Effects in Multiple MyelomaNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      12/08/20075:30PMBusiness WireAVN944 Biomarkers Correlate with Clinical Effects and Disease Stabilization in Adult AML PatientsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      11/14/20077:46AMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      11/14/20076:01AMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Notice of Effectiveness (EFFECT)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      11/07/20075:00PMEdgar (US Regulatory)Avalon Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
       Showing the most relevant articles for your search:NASDAQ:AVRX